10P HER2 loss and PAM50 dynamics after neoadjuvant therapy (NAT) in HER2-positive (HER2+) early breast cancer (BC)

Autor: Morganti, S., Brasó-Maristany, F., Rey, M., Goberna, G., Pascual, T., Schettini, F., Conte, B., Bravo, R. Gomez, Fructuoso, I. Garcia, Solis, E. Segui, Galván, P., Torres, E. Sanfeliu, Gonzalez-Farre, B., Losada, M.J. Vidal, Adamo, B., Munoz, M., Lin, N., Tolaney, S.M., Prat, A., Saez, O. Martinez
Zdroj: In ESMO Open May 2023 8(1) Supplement 4
Databáze: ScienceDirect